ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Baby blues or postpartum depression? How to tell the difference and when to seek treatment

Many women feel tired, anxious and a little down after delivering a baby. Persistent symptoms could mean it's more than just the baby blues. In this episode of NewsMD's "Health Fusion," Viv Williams talks to an OBGYN physician about warning signs and treatment options.

A new mother sits alone and looks sad
Postpartum depression is more severe than the baby blues. Fotolia
We are part of The Trust Project.

ROCHESTER — Postpartum depression is real and can be treated. The Centers for Disease Control and Prevention (CDC) website notes that 1 in 8 women experience symptoms of postpartum depression and the number of women diagnosed is on the rise.

"It's normal to feel happy, sad and frustrated after having a baby," says Dr. Melissa Richards, an obstetrician and gynecologist at Olmsted Medical Center. "But if you're concerned that this is impacting your life, if you have concerns that this is never going to get better or if you're not sleeping, reach out to your healthcare provider because treatment can help."

Richards says postpartum depression is more serious than the baby blues, which usually go away within two weeks. She says symptoms that persist or worsen are warning signs that should be taken seriously.

Treatment may come in three forms.

"There are medications available for the treatment of anxiety and depression," says Richards. "And I tell women that this doesn't mean you're always going to be on these medications. We just want to get you on the lowest dose where we can have you so you're essentially asymptomatic and feeling like you can function."

ADVERTISEMENT

Richards says the other option is therapy, such as talk therapy or cognitive behavioral therapy. The third option is a combination of both.

Symptoms of postpartum depression include:

  • Sadness
  • Anxiety
  • Feelings of emptiness and/or helplessness
  • Excessive crying
  • Anger
  • Fear that you may hurt yourself or your baby

Again, Richards says treatment can be very effective and any woman who develops symptoms during the year after delivering a baby, should consider contacting their health care provider for help.
To hear a more in-depth discussion with Dr. Richards about postpartum depression, check out the link below.

Are you depressed or is it just the baby blues? In this episode of the NewsMD podcast, "Health Fusion," Viv Williams and an Olmsted Medical Center obstetrician and gynecologist discuss risks, symptoms and treatment for postpartum depression.

Health_Fusion-1400x1400.jpg

Follow the  Health Fusion podcast on  Apple,   Spotify and  Google podcasts. For comments or other podcast episode ideas, email Viv Williams at  vwilliams@newsmd.com. Or on Twitter/Instagram/FB @vivwilliamstv.

MORE HEALTH FUSION:
Being in the hospital can be stressful and scary for both kids and adults. And after a painful surgery the last thing you might think would feel good and be helpful is a massage. In this episode of NewsMD's "Health Fusion," Viv Williams talks to a massage therapist about how certain types of massage may help reduce stress and anxiety. And in the process, it may also help ease pain.

What to read next
Earlier this month, Traverse County Attorney Matthew Franzese filed a petition with District Court Judge Thomas Gilligan Jr. asking to intervene in the case. Gilligan in July handed a victory to abortion providers who had filed a lawsuit in 2019 challenging state regulations, including a 24-hour wait period for the procedure.
Bebtelovimab is designed as a treatment option for those newly diagnosed with COVID-19 who cannot take Paxlovid and are deemed at high risk of severe outcomes. It replaces a series of monoclonal treatments that no longer are effective against virus due to mutation.
The JRMC Cancer Center, which was fully funded by donors in the community, started seeing patients in June 2019.
For decades, the drug industry has yelled bloody murder each time Congress considered a regulatory measure that threatened its profits. But the hyperbole reached a new pitch in recent weeks as the Senate moved to adopt modest drug pricing negotiation measures in the Inflation Reduction Act.